The health-care utilization and economic burden in patients with genetic skeletal disorders
© 2024. The Author(s)..
BACKGROUND: Most genetic skeletal disorders (GSD) were complex, disabling and life-threatening without effective diagnostic and treatment methods. However, its impacts on health system have not been well studied. The study aimed to systematically evaluate the health-care utilization and economic burden in GSD patients.
METHODS: The patients were derived from 2018 Nationwide Inpatient Sample and Nationwide Readmissions Database. GSD patients were extracted based on International Classification of Diseases-10th revision codes.
RESULTS: A total of 25,945 (0.12%) records regarding GSD were extracted from all 21,400,282 records in NIS database. GSD patients were likely to have significantly longer length of stay (6.50 ± 0.08 vs. 4.63 ± 0.002, P < 0.001), higher total charges ($85,180.97 ± 1,239.47 vs. $49,884.26 ± 20.99, P < 0.001), suffering more procedure, diagnosis and transferring records in comparison to patients with common conditions. GSD patients had a significantly higher 30-day all-cause readmission rate based on Nationwide Readmissions Database.
CONCLUSIONS: The heavy health-care utilization and economic burden emphasized the urgency for policy leaders, scientific and pharmaceutical researchers, health care providers and employers to identify innovative ways and take effective measurements immediately, and eventually to help improve the care, management, and treatment of these devastating diseases.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Orphanet journal of rare diseases - 19(2024), 1 vom: 04. März, Seite 99 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Liu, Luna [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Economic burden |
|---|
| Anmerkungen: |
Date Completed 06.03.2024 Date Revised 07.03.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s13023-024-03102-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369287282 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369287282 | ||
| 003 | DE-627 | ||
| 005 | 20240307232536.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240305s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13023-024-03102-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1319.xml |
| 035 | |a (DE-627)NLM369287282 | ||
| 035 | |a (NLM)38438867 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Liu, Luna |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The health-care utilization and economic burden in patients with genetic skeletal disorders |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.03.2024 | ||
| 500 | |a Date Revised 07.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a BACKGROUND: Most genetic skeletal disorders (GSD) were complex, disabling and life-threatening without effective diagnostic and treatment methods. However, its impacts on health system have not been well studied. The study aimed to systematically evaluate the health-care utilization and economic burden in GSD patients | ||
| 520 | |a METHODS: The patients were derived from 2018 Nationwide Inpatient Sample and Nationwide Readmissions Database. GSD patients were extracted based on International Classification of Diseases-10th revision codes | ||
| 520 | |a RESULTS: A total of 25,945 (0.12%) records regarding GSD were extracted from all 21,400,282 records in NIS database. GSD patients were likely to have significantly longer length of stay (6.50 ± 0.08 vs. 4.63 ± 0.002, P < 0.001), higher total charges ($85,180.97 ± 1,239.47 vs. $49,884.26 ± 20.99, P < 0.001), suffering more procedure, diagnosis and transferring records in comparison to patients with common conditions. GSD patients had a significantly higher 30-day all-cause readmission rate based on Nationwide Readmissions Database | ||
| 520 | |a CONCLUSIONS: The heavy health-care utilization and economic burden emphasized the urgency for policy leaders, scientific and pharmaceutical researchers, health care providers and employers to identify innovative ways and take effective measurements immediately, and eventually to help improve the care, management, and treatment of these devastating diseases | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Economic burden | |
| 650 | 4 | |a Genetic skeletal disorder | |
| 650 | 4 | |a Health system | |
| 650 | 4 | |a Health-Care utilization | |
| 650 | 4 | |a Rare bone disease | |
| 700 | 1 | |a Shi, Yingzhou |e verfasserin |4 aut | |
| 700 | 1 | |a Fan, Xiude |e verfasserin |4 aut | |
| 700 | 1 | |a Yao, Yangyang |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Wanhong |e verfasserin |4 aut | |
| 700 | 1 | |a Tian, Yang |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Huixiao |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Zongyue |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yanzhou |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Chao |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Orphanet journal of rare diseases |d 2006 |g 19(2024), 1 vom: 04. März, Seite 99 |w (DE-627)NLM163016410 |x 1750-1172 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2024 |g number:1 |g day:04 |g month:03 |g pages:99 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13023-024-03102-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2024 |e 1 |b 04 |c 03 |h 99 | ||